Revenue
$753.21M
Fiscal year ended 2026-06-30Operating income
-$97.19M
Fiscal year ended 2026-06-30Free cash flow
Unavailable
Fiscal year ended 2026-06-30Valuation, from the filing
| Public float | $10.10B | Market value of stock held by non-affiliates, as stated on the cover page for 2025-06-30 |
|---|---|---|
| Float / net income | 78.7× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / revenue | 4.3× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / equity | 18.7× | A lower bound on the multiple, because affiliate holdings are excluded. |
Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.
How this compares in its industry
Percentile among the Services-Offices & Clinics of Doctors of Medicine filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.
| Measure | Reported | Percentile | |
|---|---|---|---|
| Revenue YoY growth | 59.0% | 100th | |
| Current ratio | 1.90x | 71th | |
| Net margin | 5.5% | 71th | |
| Operating margin | 4.5% | 71th | |
| SBC / revenue | 5.8% | 71th |
Hims & Hers Health, Inc. (HIMS) reported revenue of $753.21M and net income of -$86.29M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Hims & Hers Health, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Offices & Clinics of Doctors of Medicine.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $753.21M | $608.10M | $617.82M | $598.98M | $544.83M | $586.01M | $481.14M | $401.56M | $315.65M | $278.17M |
| Cost of revenue | $272.41M | $211.32M | $173.38M | $156.92M | $128.64M | $155.32M | $111.60M | $83.67M | $59.04M | $49.08M |
| Gross profit | $480.80M | $396.79M | $444.44M | $442.06M | $416.20M | $430.69M | $369.54M | $317.89M | $256.61M | $229.10M |
| Operating income | -$97.19M | -$78.32M | $9.19M | $11.81M | $26.72M | $57.90M | $18.60M | $22.37M | $11.03M | $9.90M |
| Net income | -$86.29M | -$92.12M | $20.60M | $15.77M | $42.50M | $49.48M | $26.02M | $75.59M | $13.30M | $11.13M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 231.75M | shares 228.36M | Unavailable | shares 248.68M | shares 256.78M | shares 246.61M | Unavailable | shares 235.07M | shares 234.79M | shares 229.36M |
| Pretax income | -$92.63M | -$101.55M | $18.35M | $12.22M | $32.85M | $60.50M | $22.29M | $23.59M | $13.42M | $12.40M |
| Income tax expense | -$6.34M | -$9.44M | -$2.25M | -$3.55M | -$9.65M | $11.01M | -$3.73M | -$52.00M | $127.00K | $1.28M |
| Diluted EPS | $-0.37 | $-0.40 | Unavailable | $0.06 | $0.17 | $0.20 | Unavailable | $0.32 | $0.06 | $0.05 |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| General & administrative | $165.38M | $109.67M | $76.16M | $80.68M | $67.27M | $48.61M | $48.03M | $44.62M | $40.55M | $34.57M |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $609.81M | $222.27M | $228.62M | $345.78M | $1.12B | $273.74M | $220.58M | $165.52M | $129.30M | $105.24M |
| Total assets | $3.63B | $2.27B | $2.15B | $2.23B | $1.88B | $891.71M | $707.54M | $602.26M | $480.50M | $448.11M |
| Current assets | $1.38B | $1.05B | $767.64M | $845.26M | $1.36B | $446.96M | $395.83M | $326.38M | $290.92M | $261.73M |
| Total liabilities | $3.30B | $1.82B | $1.61B | $1.65B | $1.31B | $342.45M | $230.82M | $162.21M | $118.53M | $103.62M |
| Current liabilities | $1.48B | $618.78M | $404.43M | $450.78M | $272.23M | $280.36M | $221.37M | $152.64M | $108.67M | $93.32M |
| Total equity incl. NCI | $324.07M | $446.17M | $540.93M | $580.98M | $562.70M | $549.26M | $476.72M | $440.05M | $361.97M | $344.48M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $87.78M | $79.07M | $80.13M | $105.99M | $141.80M | $76.10M | $64.43M | $49.11M | $40.59M | $29.83M |
| Accounts receivable | $375.29M | $149.62M | $32.15M | Unavailable | Unavailable | Unavailable | $6.10M | Unavailable | Unavailable | Unavailable |
| Goodwill | $1.10B | $342.84M | $278.32M | $259.24M | $117.75M | $117.75M | $112.73M | $112.73M | $110.88M | $110.88M |
| Long-term debt | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts payable | $501.30M | $306.86M | $143.28M | $198.41M | $105.01M | $108.92M | $91.18M | $75.44M | $57.10M | $43.92M |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$35.94M | $89.36M | $61.31M | $148.72M | -$19.12M | $109.09M | $86.38M | $85.27M | $53.59M | $25.84M |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Investing cash flow | $84.54M | -$15.45M | -$83.68M | -$887.40M | -$21.09M | -$32.80M | -$17.21M | -$10.41M | -$4.47M | $13.04M |
| Financing cash flow | $341.76M | -$77.88M | -$97.52M | -$39.01M | $889.17M | -$23.02M | -$13.65M | -$38.82M | -$25.06M | -$30.31M |
| Net change in cash | $387.54M | -$6.35M | -$117.16M | -$779.17M | $849.99M | $53.52M | $55.07M | $36.22M | $24.06M | $8.57M |
| Stock-based compensation | $42.12M | $36.86M | $34.49M | $40.17M | $35.73M | $24.86M | $24.35M | $24.90M | $24.04M | $19.03M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | $80.48M | $9.48M | $0 | $0 | $5.00M | $30.04M | $19.93M | $28.06M |
| Depreciation & amortization | $29.48M | $21.95M | $18.09M | $17.67M | $10.46M | $8.28M | $6.06M | $4.38M | $3.64M | $3.00M |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | 63.8% | 65.2% | 71.9% | 73.8% | 76.4% | 73.5% | 76.8% | 79.2% | 81.3% | 82.4% |
| Operating margin | -12.9% | -12.9% | 1.5% | 2.0% | 4.9% | 9.9% | 3.9% | 5.6% | 3.5% | 3.6% |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | 5.6% | 6.1% | 5.6% | 6.7% | 6.6% | 4.2% | 5.1% | 6.2% | 7.6% | 6.8% |
| Current ratio | 0.93x | 1.69x | 1.90x | 1.88x | 4.98x | 1.59x | 1.79x | 2.14x | 2.68x | 2.80x |
| Revenue YoY growth | 38.2% | 3.8% | 28.4% | 49.2% | 72.6% | 110.7% | 95.1% | 77.1% | 51.8% | 45.8% |
| Net margin | -11.5% | Unavailable | 3.3% | 2.6% | 7.8% | Unavailable | 5.4% | 18.8% | Unavailable | Unavailable |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | -12.2% | -29.1% | -29.4% | 18.2% | -16.8% | -220.4% | 0.9% | 10.3% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open HIMS in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-10View SEC filing
10-Q · Filed 2026-05-11View SEC filing
10-K · Filed 2026-02-23View SEC filing
10-Q · Filed 2025-11-03View SEC filing
10-Q · Filed 2025-08-04View SEC filing
10-Q · Filed 2025-05-05View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.